share_log

Teladoc Health | DEFA14A: Others

Teladoc Health | DEFA14A: Others

Teladoc Health | DEFA14A:其他
SEC announcement ·  04/09 16:12
Moomoo AI 已提取核心信息
Teladoc Health has filed a DEFA14A proxy statement with the United States Securities and Exchange Commission (SEC) in Washington, D.C. The filing, which is pursuant to Section 14(a) of the SEC regulations, is a preparatory step for upcoming corporate actions that require shareholder votes. Proxy statements are typically filed ahead of annual meetings where shareholders vote on various company matters, including the election of directors, executive compensation, and other significant corporate governance issues. The exact date of the meeting and the matters to be voted on have not been specified in the announcement.
Teladoc Health has filed a DEFA14A proxy statement with the United States Securities and Exchange Commission (SEC) in Washington, D.C. The filing, which is pursuant to Section 14(a) of the SEC regulations, is a preparatory step for upcoming corporate actions that require shareholder votes. Proxy statements are typically filed ahead of annual meetings where shareholders vote on various company matters, including the election of directors, executive compensation, and other significant corporate governance issues. The exact date of the meeting and the matters to be voted on have not been specified in the announcement.
Teladoc Health 已向华盛顿特区的美国证券交易委员会 (SEC) 提交了一份 DEFA14A 委托声明。该文件根据美国证券交易委员会法规第 14 (a) 条提交,是为即将到来的需要股东投票的公司行动做准备步骤。委托书通常在年会之前提交,在年会之前,股东对各种公司事务进行投票,包括董事选举、高管薪酬和其他重大公司治理问题。公告中没有具体说明会议的确切日期和有待表决的事项。
Teladoc Health 已向华盛顿特区的美国证券交易委员会 (SEC) 提交了一份 DEFA14A 委托声明。该文件根据美国证券交易委员会法规第 14 (a) 条提交,是为即将到来的需要股东投票的公司行动做准备步骤。委托书通常在年会之前提交,在年会之前,股东对各种公司事务进行投票,包括董事选举、高管薪酬和其他重大公司治理问题。公告中没有具体说明会议的确切日期和有待表决的事项。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息